News

ETC Baltimore, dedicated to elevating Baltimore as a national leader in tech startups, announces the opening of its inaugural ETC Venture Hub at Connect Labs Baltimore in the newly constructed 4MLK Building in the University of Maryland BioPark. This milestone marks a significant step in Baltimore’s efforts to strengthen its ecosystem for life science startups and attract high-potential companies to the city.

The ETC Venture Hub at Connect Labs Baltimore is a dedicated space designed to provide early-stage life science companies with the technology, capital, talent and resources needed to successfully grow and scale. Offering desk space, expert support, and a collaborative community, the hub serves as a launchpad for startups. This is part of ETC’s broader strategy to establish multiple footprints throughout the city. By expanding its reach, ETC aims to create a more inclusive and robust entrepreneurial ecosystem, ensuring innovators in all areas of Baltimore have access to the tools and support they need to thrive.

For the second year in a row, the BioHealth Capital Region (BHCR) has been ranked as a Top 3 BioCluster Hub by Genetic Engineering and Biotechnology News (GEN). Montgomery County, Maryland, located in the heart of the BHCR, offers unparalleled assets, including proximity to the FDA and NIH, making it a premier destination for biohealth innovation. Adding to its already successful programs, Montgomery County is launching new initiatives to further support biotech success in 2025 and beyond.

Existing programs continue to provide strong support for growing companies. The Executive-in-Residence Program connects entrepreneurs in the County with experienced mentors who guide commercialization strategies and accelerate growth. The SBIR Matching Program helps companies amplify their non-dilutive funding by providing additional resources to build on their Small Business Innovation Research (SBIR) awards. Additionally, the Investor Tax Credit incentivizes private investment in Maryland’s innovative companies, making it more attractive for investors to support local startups.

Building on these efforts, Montgomery County is introducing the Technology Innovation Fund and the Founders Fund, which will provide grants of up to $200,000 and $100,000, respectively. These programs are designed to support commercialization milestones for companies in sectors such as healthtech, life sciences, artificial intelligence, and quantum technologies. Additional incentives like the expanded MOVE program and JOBS grants will make it even easier for companies to establish and grow their presence in the county. Partnerships with the Henry Jackson Foundation and BioHub will further enhance the local ecosystem by creating new opportunities and resources for the biotech sector. Applications for the Technology Innovation and Founders Funds are due by January 31, 2025.

BALTIMORE, January 28, 2025 – KaloCyte, Inc., a pre-clinical biotech startup company developing a bio-inspired red blood cell substitute called ErythroMer™, announced today that it has been selected to join Blue Knight, a strategic collaboration between the Biomedical Advanced Research and Development Authority (‘BARDA’) and Johnson & Johnson’s global incubator network, JLABS, supporting early-stage innovation and incubation of science and technologies to improve health security and unlock new approaches to solving health issues.

KaloCyte, a University of Maryland BioPark affiliate, will be a virtual resident within JLABS, a premier life science incubator program. They will keep their laboratories and offices in downtown Baltimore where they collaborate closely with the University of Maryland School of Medicine’s Center for Blood Oxygen Transport & Hemostasis (CBOTH).

LEIDEN, Netherlands, January 28, 2025 / Biotech Newswire / — MIMETAS, a global leader in human disease modeling, has launched OrganoPlate UniFlow (UF), the first commercially available unidirectional, gravity-driven pumpless flow system for drug discovery and disease research. This innovative platform debuts at SLAS 2025 as a key addition to MIMETAS’ service portfolio.

OrganoPlate UF addresses challenges in traditional flow systems by enabling physiologically accurate tissue models that replicate natural biological conditions. With unidirectional, gravity-driven flow, this system eliminates the need for external pumps, simplifying operation while enhancing model accuracy. Supporting up to 512 chips in a single setup, the technology is ideal for rigorous scientific studies and large-scale screening, accelerating research without compromising biological relevance.

HANOVER, MD, Jan. 27, 2025 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, today announced the pricing of its “reasonable best efforts” public offering with participation from the Company’s Chief Executive Officer, certain board members, and existing institutional investors of the Company, along with a healthcare focused institutional investor, consisting of 8,050,672 shares of common stock (or pre-funded warrants in lieu thereof) and accompanying Series A warrants to purchase up to 8,050,672 shares of common stock (or pre-funded warrants in lieu thereof) and Series B warrants to purchase up to 4,025,336 shares of common stock at a combined purchase price per share (and accompanying warrants) of $0.615 for the institutional investors and $0.7975 for the Company’s Chief Executive Officer and certain board members.

COLUMBIA, Md., (January 27, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced a recent $100,000 investment in ReBokeh through the Pre-Seed Builder Fund, a key program under the Social Impact Funds. This initiative provides early-stage businesses with access to funding and resources designed to support their growth and success.

“Having TEDCO in our corner has been incredibly valuable for ReBokeh,” said Rebecca Rosenberg, CEO of ReBokeh. “As a company that planted its roots in Baltimore, we’re both excited and immensely proud to continue being a part of the growing startup scene that calls Maryland home.”

BALTIMORE, Jan. 24, 2025 /PRNewswire/ — In two separate procedures, MedStar Health cardiac experts at MedStar Union Memorial Hospital reached new heights in cardiovascular care when they performed the state’s and the system’s first transcatheter tricuspid valve replacements (TTVR) using a recently FDA-approved valve, to treat life-threatening tricuspid regurgitation. On Jan. 7th, the male and female patients, both in their 80’s, received the revolutionary valves delivered via a catheter, foregoing the need for conventional open-heart surgery.

FREDERICK, Md., Jan. 27, 2025 (GLOBE NEWSWIRE) — Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that it has received written agreement from the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process on the overall design of the Company’s planned Phase 3 AURORA trial for Descartes-08, its lead mRNA cell therapy candidate, in myasthenia gravis (MG). The SPA agreement indicates that the FDA has determined that the proposed trial design is acceptable to support a future Biologics License Application for Descartes-08 in MG, subject to the ultimate outcome of the trial.

COLUMBIA, Md., Jan. 24, 2025 /PRNewswire/ — TEDCO, Maryland’s economic engine for technology companies, announced nine awardees for the inaugural Maryland Student Venture Showcase and Pava LaPere Innovation Awards. The awards, funded by the State of Maryland through the Pava LaPere Legacy of Innovation Act of 2024, recognize and support outstanding student entrepreneurs from colleges and universities in the Baltimore–Towson–Columbia metropolitan statistical area.

“The Maryland Student Venture Showcase and Pava LaPere Innovation Awards are a testament to the incredible talent and innovation coming out of Maryland’s colleges and universities,” said Troy LeMaile-Stovall, TEDCO CEO. “We are excited to support these outstanding student entrepreneurs as they work to grow successful businesses.”